循证医学对慢性充血性心力衰竭治疗现状的评价

摘要

@@循证医学对慢性充血性心力衰竭治疗现状的评价rn郑刚　 刘兆昶　 rn关键词：心力衰竭，充血性；　循证医学；　治疗学rn分类号：R541.6+1　文献标识码：Arn文章编号：1008-6315(2001)01-0001-03 rn作者单位：郑刚（天津医科大学第一中心医院心内科 300011）　rn　　　　　刘兆昶（天津第三医院心内科）　rn参考文献：rn［1］郑　刚，刘兆昶.循证医学对调脂治疗现状的评价.国外医学．心血管疾病分册，2000，27(2):109-111rn［2］Evidence-Based Medicine Working Group.Evidence-Based Medicine:a new approach to teaching the practice of medicine.JAMA,1992,268(17):2420-2425rn［3］Gavg R,Yusuf S.Overview of randomized trial of angiotensin converting enzyme inhibitors on mortality and morbidity in patients with heart failure.Collaborative Group on ACE in-hibitors.JAMJ,1995,273(18):1450rn［4］ACC/AHA Task Force Report.Guideline for the evaluation and management of heart failure.JACC,1995,26(5):1376-1398rn［5］胡大一.慢性充血性心力衰竭药物治疗的现代观点与最新进展.中国实用内科杂志，2000，20(1)：6-8rn［6］Advisory Council to Imptove Outcome Nationwide in Heart Failure.Consensus recommendations for the management of chronic heart failure.Am J Cardiol,1999,83(2A):1-30rn［7］CIBIS-ⅡInvestigators and Committees.The cardiac insuffi-ciency bisoprolol studyⅡ(CIBIS-Ⅱ) a randomised trial.Lancet,1999,353(9146):9rn［8］MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Inter-vention Trial in congestive Heart Failure (MERIT-HF.Lancet,1999,353(9169):2001rn［9］Cleland JGF,McGowan J,Clark A.The evidence for β blockers in heart failure.BMJ,1999,318(7187):824-825rn［10］Rahimtoola SH,Tak T.The use of digitalis in heart failure.Curr Prol Cardiol,1996,21(2):781rn［11］Dangas G,Gorlin R.The role of digitalis in the management of heart failure:old molecule new respectability.In:Coats A，ed.Controversies in the management of heart failure.Lond:Churchill Livingstone,1997.83-86rn［12］The Digitalis Investigation Group:The effect of digoxin on mortality and morbidity in patients with heart failure.N Engl J Med,1997,336(8):525-533rn［13］Struthers AD.Aldosterone escape during ACE inhibitor therapy in chronic heart failure.Eur Heart J,1995,16(Suppl N):103-106rn［14］Pitt B,Segal R,Martinez FA,et al.Randomised trial of losartan versus captopril in patients over 65 with heart failure.Lancet,1997,349(9054):747-752rn［15］What future now for angiotensin Ⅱ antagonists.Scrip,1999.22rn［16］Cohn JN,Ziesche S,Smith R,et al.Effect of the calcium anta-gonist felodipine as supplementary vasodilator therapy in pa-tients with chronic heart failure treated with enalapril:V-HeFTⅢ,Vasodilator-Heart Failure Trail(V-HeFT) Study Group.Circulation,1997,96(3):856-863rn［17］Packer M,O'connor CM,Ghali JK,et al.Effect of amlodipine on morbidity and mortality in severe chronic heart failure.Pro-spective Randomized Amlodipine Survival Evaluation Study Group (PRAIDE).N Eng J Med,1996,335(15):1107-1114rn［18］The PROMIDE Study Research Group.Effect of oral milirinone on mortality in severe chronic heart failure.N Engl J Med,1991,325(21):1468rn［19］Leier CV.Positive inotropic therapy:an upade and new agents.Curr Prol Cardiol,1996,21(12):781rn收稿日期：2000年7月11日